P/E at 65.71 vs Industry's 65.62: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Parity?

The P/E ratio of Apollo Hospitals Enterprise Ltd. at 65.71 is almost identical to the industry’s 65.62, indicating that the market values the company in line with its sector peers. This suggests that investors are pricing in growth expectations and profitability consistent with the hospital sector’s outlook. The large-cap stock’s market capitalisation stands at ₹1,27,828.15 crores, underscoring its dominant position within the hospital industry. The valuation parity raises the question of whether the stock’s premium performance over the past year is fully reflected in its current price — previously rated Hold, what is Apollo Hospitals’ current rating? The close alignment with sector P/E also implies limited valuation risk relative to peers, but it leaves little margin for error in earnings delivery.

Performance Across Timeframes: Momentum and Divergence

Examining the stock’s returns reveals a compelling narrative of sustained outperformance. Over one year, Apollo Hospitals has gained 20.51%, contrasting sharply with the Sensex’s 7.64% decline. The year-to-date return is even more impressive at 26.24%, while the three-month performance shows a robust 14.40% gain against the Sensex’s negative 1.62%. This consistent alpha generation extends to longer horizons as well, with three-year returns at 70.87%, five-year returns at 126.95%, and a remarkable ten-year return of 565.41%, far exceeding the Sensex’s respective 14.58%, 44.23%, and 174.82% gains.

Shorter-term momentum, however, has shown signs of moderation. The stock’s one-month return of 4.74% is positive but less pronounced, and the day’s performance saw a decline of 0.54%, slightly underperforming the Sensex’s 0.45% fall. Notably, the stock opened with a gap down of 3.45% today and touched an intraday low of ₹8,630.15, indicating some immediate selling pressure. This recent weakness follows three consecutive days of gains, suggesting a potential pause or consolidation phase — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Mixed Signals

The technical picture for Apollo Hospitals reveals a nuanced trend. The stock currently trades above its 50-day, 100-day, and 200-day moving averages, signalling a longer-term bullish trend. However, it remains below the 5-day and 20-day moving averages, indicating short-term weakness or a pullback within the broader uptrend. This configuration often suggests a temporary correction or consolidation phase rather than a full reversal. The recent gap down and intraday low reinforce this interpretation, as the stock appears to be testing support levels established by the longer-term averages. Investors may find this setup indicative of a potential buying opportunity if the stock stabilises above these key moving averages — is this a recovery or a dead-cat bounce?

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances across constituent stocks. Apollo Hospitals stands out as a large-cap leader, outperforming many peers in both short and long-term horizons. The sector’s average P/E of 65.62 reflects elevated valuations, consistent with the healthcare industry's growth prospects and defensive qualities. The stock’s ability to maintain valuation parity while delivering superior returns highlights its relative strength within the sector. However, the recent underperformance relative to the sector today (-1.82%) and the intraday volatility suggest that sector-wide headwinds or profit-taking may be influencing price action.

Rating Context: Previously Hold, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was updated on 11 May 2026, reflecting the company’s evolving fundamentals and market performance. While the current rating is not disclosed, the reassessment coincides with the stock’s strong relative performance and valuation alignment with the sector. This update invites investors to consider how the new rating integrates the company’s recent momentum and valuation metrics — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: What the Data Collectively Shows

The data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a valuation closely aligned with its sector peers, yet delivering markedly superior returns across multiple timeframes. The one-year and longer-term performance metrics demonstrate sustained alpha generation, while the short-term technical indicators suggest a pause or minor correction within an overall uptrend. The stock’s recent intraday weakness and gap down highlight near-term volatility, but its position above key long-term moving averages provides a foundation of support. The reassessment of the rating from Hold to a new status reflects these evolving dynamics and invites further scrutiny of the stock’s prospects — what is the current rating?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →